DRKS00023890已完成不适用
Retrospective analysis of patients with stage IV non-squamous lung cancer with and without TTF-1- and KRAS-G12-mutation
Krankenhaus Martha-Maria Halle-Dölau0 个研究点目标入组 207 人开始时间: 2020年12月17日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 207
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 one（—）
- 性别
- All
入选标准
- •histologically confirmed non-squamous lung cancer stage IV. Patients from 2016-2019 follow up until the end of 2020
排除标准
- •missing mutation analysis, other mutations
研究者
相似试验
进行中（未招募）
不适用
Clinical trial of first line treatment with carboplatin and paclitaxel plus bevacizumab for advanced ovarian cancer patients.advanced ovarian cancerMedDRA version: 15.0Level: PTClassification code 10033128Term: Ovarian cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-003043-29-ITISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE G. PASCALE
已完成
4 期
Implantable Cardiac Device Long Term Observational study (Panorama OS)CTRI/2009/091/000420Medtronic Bakken Research Centre Endepolsdomein GW MaastrichtThe Netherlands10,000
已完成
不适用
A cohort study in patients with StageIIIB/IVnon-small cell lung cancer, who had treated as 1st-line Conbination therapy of Carboplatin/Paclitaxel/Bavacizumab, and 2nd-line by Erlotinibnon-small cell lung cancerJPRN-UMIN000006079Yamagata University School of Medicine44
招募中
1 期
Clinical study on the treatment of stage III - IV colorectal cancer of spleen deficiency and essence deficiency type with anticancer essence formulaColorectal cancerITMCTR2000003853onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
已完成
不适用
Retrospective observational study in patients with renal cell carcinoma treated by everolimus, mTOR inhibitorAdvanced renal cell carcinomaJPRN-UMIN000004730Department of Urology, Kinki University School of Medicine300